Argentina Inhalation & Nasal Spray Generic Drugs Market Size & Outlook

The inhalation & nasal spray generic drugs market in Argentina is expected to reach a projected revenue of US$ 338.2 million by 2030. A compound annual growth rate of 9% is expected of Argentina inhalation & nasal spray generic drugs market from 2024 to 2030.
Revenue, 2023 (US$M)
$185.4
Forecast, 2030 (US$M)
$338.2
CAGR, 2024 - 2030
9%
Report Coverage
Argentina

Argentina inhalation & nasal spray generic drugs market, 2018-2030 (US$M)

Argentina

Related Markets

Argentina inhalation & nasal spray generic drugs market highlights

  • The Argentina inhalation & nasal spray generic drugs market generated a revenue of USD 185.4 million in 2023 and is expected to reach USD 338.2 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 9% from 2024 to 2030.
  • In terms of segment, bronchodilators was the largest revenue generating drug class in 2023.
  • Combination Drugs is the most lucrative drug class segment registering the fastest growth during the forecast period.


Inhalation & nasal spray generic drugs market data book summary

Market revenue in 2023USD 185.4 million
Market revenue in 2030USD 338.2 million
Growth rate9% (CAGR from 2023 to 2030)
Largest segmentBronchodilators
Fastest growing segmentCombination Drugs
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBronchodilators, Combination Drugs, Corticosteroids, Decongestant Sprays, Antihistamines, Other Drug Classes
Key market players worldwideTeva Pharmaceutical Industries Ltd, Cipla Ltd DR, Novartis AG ADR, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries, Beximco Pharmaceuticals Ltd DR, Mylan, Akorn, Apotex Inc., Nephron Pharmaceuticals


Other key industry trends

  • In terms of revenue, Argentina accounted for 0.9% of the global inhalation & nasal spray generic drugs market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil inhalation & nasal spray generic drugs market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 764.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Inhalation & Nasal Spray Generic Drugs Market Scope

Inhalation & nasal spray generic drugs market segmentation & scope
Bronchodilators
Combination Drugs
Corticosteroids
Decongestant Sprays
Antihistamines
Other Drug Classes
Asthma
Chronic Obstructive Pulmonary Disease
Allergic Rhinitis
Others Indications
Adult Patient
Pediatric Patient
Geriatric Patient
Homecare
Hospitals
Other End-users
Retail Pharmacies
Hospitals Pharmacies
Online Pharmacies

Inhalation & Nasal Spray Generic Drugs Market Companies

Name Profile # Employees HQ Website

Argentina inhalation & nasal spray generic drugs market size, by drug class, 2018-2030 (US$M)

Argentina Inhalation & Nasal Spray Generic Drugs Market Outlook Share, 2023 & 2030 (US$M)

Argentina inhalation & nasal spray generic drugs market size, by drug class, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more